Study Shows Association Between Current Smoking and Lower Risk for Parkinson Disease

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on March 3, 2026.

via HealthDay

TUESDAY, March 3, 2026 -- Current smoking is associated with a lower risk of Parkinson disease, while recent and sustained quitters have lower risks for all-cause mortality, according to a study published online Feb. 25 in Neurology.

Sung-Ho Ahn, from the Yonsei University College of Medicine in Seoul, South Korea, and colleagues conducted a large-scale retrospective cohort study involving current smokers aged 40 years or older to examine the association between longitudinal changes in smoking status and risks for PD and all-cause mortality. Participants were categorized into persistent smokers, recent quitters, sustained quitters, and relapsed smokers.

Data were included for 410,489 eligible participants. The researchers found that persistent smokers had the lowest risk of PD during a median 9.1-year follow-up. Higher risks of PD were seen for recent quitters and sustained quitters compared with persistent smokers (subdistribution hazard ratios [95 percent confidence intervals], 1.60 [1.41 to 1.82] and 1.61 [1.42 to 1.81], respectively); no significant difference was seen for relapsed smokers versus persistent smokers (subdistribution hazard ratio, 1.05; 95 percent confidence interval, 0.87 to 1.28). Recent and sustained quitters had 3 and 17 percent lower risks of all-cause mortality, respectively, compared with persistent smokers, while no significant difference was seen for relapsed smokers.

"Our study suggests a lower risk of Parkinson's is not necessarily associated with how long someone smokes, but rather if they are currently smoking," coauthor Jun-Hyuk Lee, M.D., Ph.D., from the Eulji University School of Medicine in Seoul, South Korea, said in a statement. "Future studies are needed to better understand which components of smoking contribute to the reduced risk, and to develop safe and targeted therapies that replicate the effects of smoking for Parkinson's without the harmful health consequences."

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-04 01:42

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords